Format

Send to

Choose Destination
Bioorg Med Chem Lett. 2014 Jul 15;24(14):3006-13. doi: 10.1016/j.bmcl.2014.04.088. Epub 2014 May 6.

Targeting the homologous recombination pathway by small molecule modulators.

Author information

1
Department of Biochemistry and Molecular Biology, Drexel University College of Medicine, Philadelphia, PA 19102-1192, United States.
2
Department of Biochemistry and Molecular Biology, Drexel University College of Medicine, Philadelphia, PA 19102-1192, United States. Electronic address: amazin@drexelmed.edu.

Abstract

During the last decade, the use of small molecule (MW <500 Da) compounds that modulate (inhibit or activate) important proteins of different biological pathways became widespread. Recently, the homologous recombination (HR) pathway emerged as a target for such modulators. Development of small molecule modulators pursues two distinct but not mutually exclusive purposes: to create a research tool to study the activities or functions of proteins of interest and to produce drugs targeting specific pathologies. Here, we review the progress of small molecule development in the area of HR.

KEYWORDS:

BLM; DNA double stranded breaks; DNA repair; RAD51; RAD54; WRN

PMID:
24856061
PMCID:
PMC5568029
DOI:
10.1016/j.bmcl.2014.04.088
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center